RLMD
Relmada Therapeutics, Inc. · Healthcare
CEO Sergio Traversa sold $51K of Relmada Therapeutics, Inc.
Sold$51,238
$35.43Price
1,446Shares
−2%Stake
What RLMD did after the filing
- The stock from Tue, Feb 16 close, $38.46
- −9.2%
- S&P 500, same days
- +0.9%
Measured over 30 trading days, to the Mar 30 close.
Traded Thu, Feb 11. Filed Tue, Feb 16, 12:10 PM ET, during the session. Returns use the Feb 16 close and the Mar 30 close. Not investment advice.